Why the “Average Cost of Rehab in California” Is a Harder Question Than It Looks
Ask ten California treatment centers what a month of care costs and you will get ten different answers, and several of them will not answer at all until you hand over your insurance card. That is not a small annoyance. It is the single biggest reason families end up either overpaying badly or walking away from care they could have afforded.
Here is something worth saying plainly at the top: no government agency in California publishes an official average price for private-pay addiction treatment. The state licenses and certifies facilities through the Department of Health Care Services, and the federal government surveys them every year through SAMHSA, but neither one collects or releases a statewide price list. Anyone who quotes you a single, confident “average cost of rehab in California” is either summarizing marketing pages or quoting a national figure and dressing it up as local.
So this guide does something different. It separates what is actually documented in peer-reviewed research and federal data from what is simply the going rate in the California market, and it labels which is which. If you want the wider international picture for context, our companion piece on rehab costs around the world covers how the United States compares to other systems.
The short version
In California, a 30-day residential inpatient stay commonly runs between roughly $15,000 and $40,000 at a standard private facility, with nonprofit and county-contracted programs falling far below that and luxury coastal centers running well above it. A full course of intensive outpatient care typically lands somewhere between $3,500 and $12,000. Both figures collapse toward zero for people who qualify for Drug Medi-Cal.
Those spreads exist because “rehab” is not one product. It is a ladder of clinical intensity, and where you sit on that ladder drives nearly everything about the bill.
Inpatient vs. Outpatient Rehab Cost in California: A Side-by-Side Comparison of What Each Level of Care Actually Charges
The single most useful mental model is this: you are not buying a program, you are buying supervised hours. A residential bed buys you 168 hours of oversight a week, including a roof, food, nursing coverage, and a locked medication cabinet. An intensive outpatient program buys you nine to fifteen clinical hours a week and nothing else. That ratio explains most of the price gap before you get anywhere near amenities or zip codes.
The ranges below reflect self-pay prices advertised or quoted by California facilities as of early 2026. They are a market snapshot, not a government statistic, and individual quotes routinely fall outside them in both directions.
| Level of Care | Typical Length | Common CA Self-Pay Range |
|---|---|---|
| Medical detox (withdrawal management) | 3–10 days | $5,000–$15,000 total |
| Residential inpatient, standard private | 30 days | $15,000–$40,000 |
| Residential inpatient, luxury or executive | 30 days | $40,000–$100,000+ |
| Partial hospitalization (PHP) | 2–4 weeks | $7,000–$20,000 |
| Intensive outpatient (IOP) | 8–12 weeks | $3,500–$12,000 |
| Standard outpatient counseling | 12 weeks | $1,500–$5,000 |
| Medications for addiction treatment | Ongoing | $300–$600 per month |
| Sober living / recovery residence | Monthly | $1,000–$3,000 per month |
Ranges compiled from publicly advertised California facility pricing and national cost research, January 2026. Sober living is housing, not licensed treatment, and is generally not covered by insurance.
Visualizing the Cost Gap Between Residential Treatment and Intensive Outpatient Programs in California
Put the midpoints of those ranges next to each other and the shape of the problem becomes obvious. The bars below compare the typical middle of each range on a common scale, with the widest bar representing roughly $70,000.
Luxury residential, 30 days – ~$70,000
Standard residential, 30 days – ~$27,000
Partial hospitalization – ~$13,500
Medical detox, one week – ~$10,000
Intensive outpatient, full course – ~$7,750
Standard outpatient, 12 weeks – ~$3,250
Drug Medi-Cal, any level of care – $0 out of pocket
Bars show midpoints of the self-pay ranges in the table above, scaled against a $70,000 maximum. Illustrative only.
The last bar is the one most families never see. It is not a discount program or a charity waiting list. It is a benefit that roughly a third of Californians are already enrolled in, and it is discussed further down this page.
What the Peer-Reviewed Research Actually Says About Inpatient and Outpatient Substance Abuse Treatment Costs
Market pricing is one thing. Measured cost is another, and the health economics literature has been at this for a long time.
The most widely cited cost-banding study in the field, published by Michael French and colleagues in 2008, established weekly and per-episode cost bands for American substance use treatment. Inpatient care fell between $607 and $918 per week, with a full episode ranging from $2,907 to $32,361. Outpatient care ran $74 to $598 per week, with episodes between $1,132 and $5,780. Those are 2008 dollars. Adjust for medical inflation and the direction of travel is unmistakable, but the internal ratio has held remarkably steady: inpatient costs roughly five to ten times what outpatient costs on a per-week basis.
Medication costs have been measured more recently. A 2018 study led by Kathryn McCollister tracked the cost of pharmacotherapy for opioid use disorder following inpatient detoxification and found mean costs per participant of $5,416 for extended-release injectable naltrexone and $4,148 for buprenorphine-naloxone. Notably, the per-site totals varied enormously, from under $3,000 to nearly $9,000 for the same medication protocol. Site variation, not drug choice, was the bigger cost driver.
| Research Finding | Measured Figure |
|---|---|
| Inpatient treatment, weekly cost (French et al., 2008) | $607–$918 |
| Outpatient treatment, weekly cost (French et al., 2008) | $74–$598 |
| Extended-release naltrexone, per participant (McCollister et al., 2018) | $5,416 mean |
| Buprenorphine-naloxone, per participant (McCollister et al., 2018) | $4,148 mean |
| Return on every dollar invested in treatment (NIDA) | $4–$7 in reduced crime and justice costs |
Research figures are reported in the dollars of their publication year and are not inflation-adjusted here.
How Health Insurance, the Affordable Care Act, and California Senate Bill 855 Change What You Actually Pay for Addiction Treatment
Almost nobody in California pays the sticker prices above. The list price is a starting point for negotiation with an insurer, not an invoice.
Two federal laws set the floor. The Affordable Care Act made substance use disorder treatment one of the ten essential health benefits, which means individual and small-group plans have to cover it. The Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 requires that when a plan covers addiction treatment, it cannot impose harsher financial or treatment limits than it applies to comparable medical and surgical care.
California then went considerably further. Senate Bill 855, effective January 2021, rewrote the state’s parity statute. It requires state-regulated commercial plans to cover medically necessary treatment for all mental health and substance use disorders, defines medical necessity in statute, prohibits plans from limiting coverage to short-term or acute care, and, critically, requires plans to make level-of-care decisions using criteria developed by nonprofit clinical specialty associations. For substance use disorder, that means the ASAM Criteria.
The practical consequence is that a California insurer generally cannot deny residential treatment on the grounds that outpatient is cheaper, if an ASAM-based assessment places the patient at a residential level of care. That is a genuinely powerful right, and it is routinely unknown to the people who hold it. Denials can be appealed internally and then escalated to Independent Medical Review through the Department of Managed Health Care.
What you actually owe, then, is your deductible, your coinsurance percentage, and any out-of-network penalty. On a high-deductible plan, a 30-day residential stay can still mean five figures out of pocket. On a plan with a $3,000 deductible and an $8,000 out-of-pocket maximum, the same stay tops out at $8,000 no matter what the facility charges. The plan design matters more than the price tag.
Free and Low-Cost Drug and Alcohol Rehab in California Through Drug Medi-Cal and the Organized Delivery System
This is the section most cost guides skip, and it is the one that changes the most lives.
Drug Medi-Cal has funded substance use disorder treatment for eligible Medi-Cal members since 1980. Providers must be certified by the Department of Health Care Services and contract with counties. Since 2015, when California became the first state in the country to win federal approval for a Medicaid Section 1115 substance use treatment demonstration, most of the state has operated an expanded version called the Drug Medi-Cal Organized Delivery System, or DMC-ODS. As of May 2025, forty California counties participate.
What DMC-ODS covers is not a stripped-down safety net. It is a full ASAM continuum: outpatient, intensive outpatient, residential treatment for adults and youth, withdrawal management, narcotic treatment programs, medications for addiction treatment, recovery services, care coordination, and in many counties contingency management and partial hospitalization. A UCLA evaluation found that counties participating in DMC-ODS increased treatment access by 7 percent relative to non-participating counties, and 93 percent of members surveyed rated their treatment positively.
If you are enrolled in Medi-Cal, the cost of every level of care in the table above is effectively zero. If you are not enrolled but are income-eligible, enrolling is the highest-value financial move available. And for those who fall outside Medi-Cal eligibility, most county-contracted and nonprofit providers operate sliding fee scales tied to income. SAMHSA’s treatment locator lets you filter California facilities by payment type, including those that accept payment assistance.
How Location Within California Drives Rehab Pricing, From the Malibu Coast to the Central Valley
California is not one treatment market. It is at least four, and they barely resemble each other on price.
Real estate is the hidden driver. A residential facility is, financially speaking, a small licensed hospital operating out of a house. When that house sits on a bluff in Malibu, the mortgage is baked into the daily rate. When it sits in Fresno or Bakersfield, it is not. Clinical quality does not track that gradient in any reliable way, which is worth sitting with for a moment.
Relative 30-day residential pricing by California region
Malibu & coastal Los Angeles County
Orange County & coastal San Diego
San Francisco Bay Area
Inland Empire & Sacramento region
Central Valley & rural Northern California
Relative index only, based on advertised private-pay pricing patterns. Not an absolute dollar scale and not a statistical sample.
Cost-driven travel is common. Californians leave the state for care, and a growing number leave the country. Our analysis of addiction treatment costs around the world and our breakdown of rehab treatment cost in Turkey examine that trade-off, including the continuity-of-care problems it creates when someone returns home after treatment abroad.
The Hidden Costs of California Rehab That Rarely Appear on a Facility’s Published Price Sheet
The advertised price is for the program. It is often not for everything that happens inside the program.
| Cost Item | Why It Appears | Typical Impact |
|---|---|---|
| Lab and toxicology billing | Billed separately by a third-party lab | Can add thousands |
| Psychiatry and medication management | Often a separate professional fee | $200–$500 per visit |
| Detox billed as a separate admission | Different license, different rate | Adds $5,000–$15,000 |
| Lost wages during residential care | 30 days away from work | Often the largest single cost |
| Aftercare and sober living | Not licensed treatment, rarely covered | $1,000–$3,000 monthly |
| Out-of-network balance billing | Facility bills the gap to the patient | Highly variable, can be severe |
Federal law now limits surprise billing in many circumstances, but protections vary by plan type and by whether the facility is in network. Confirm in writing before admission.
Note the fourth row. Lost income is frequently the largest cost of residential treatment and almost never appears in any comparison chart. For someone earning a median California wage, thirty days away from work can exceed the entire out-of-pocket cost of an insured residential stay. It is one of the strongest practical arguments for intensive outpatient care where the clinical picture allows it, and it is a legitimate factor to raise with an assessing clinician rather than a reason to quietly downgrade your own care.
What the Cost of Untreated Addiction Looks Like Against the Cost of California Rehab
Any honest cost analysis has to price the alternative, and here the evidence is unusually consistent.
The National Institute on Drug Abuse’s research-based treatment guide reports that conservative estimates put the return on every dollar invested in addiction treatment at between $4 and $7 in reduced drug-related crime, criminal justice costs, and theft alone. Factor in health care savings and the ratio can exceed twelve to one. That is a societal figure, not a personal one, but the individual arithmetic runs in the same direction once emergency department visits, hospitalizations, legal costs, and lost employment are counted.
California’s own data gives that arithmetic weight. The state’s overdose burden climbed sharply through the fentanyl era, and while the most recent national picture shows meaningful improvement, with CDC provisional data predicting a 13.2 percent decline in overdose deaths for the twelve months ending in January 2026, the absolute numbers remain grave. The California Department of Public Health maintains a public overdose surveillance dashboard with county-level death, emergency department, and hospitalization data, updated quarterly.
None of that means an expensive program is a better program. It means the cost of doing nothing is not zero, and it is rarely accounted for when families are deciding whether they can afford care. Our broader look at the cost of behavioral health rehab treatment in the U.S. extends this comparison beyond substance use into co-occurring mental health care.
Financial Questions Worth Asking Any California Treatment Program Before You Commit
Price transparency in this industry is poor, and the burden of getting a straight answer falls on the person least equipped to carry it. These questions tend to surface the real number:
Is this program licensed or certified by the Department of Health Care Services, and what is the facility number? California maintains a public license lookup. Verify it yourself.
Does the quoted price include detox, or is detox billed as a separate admission?
Is laboratory and toxicology testing billed by you or by an outside company?
Are you in network with my plan, and can I have that confirmed in writing rather than as a verification of benefits?
What ASAM level of care are you recommending, and what assessment produced that recommendation?
If insurance authorizes fewer days than the program length, who absorbs the difference?
That fifth question matters more than people realize. Under SB 855, the level of care has to follow the ASAM assessment. If a facility recommends its most expensive program to everyone who calls, that is a signal about the business, not about the clinical picture.
About This Guide: Sourcing Standards, Methodology, and What We Cannot Tell You
Because this is financial and health information that people act on, it is worth being explicit about how it was built and where it stops.
Every regulatory, epidemiological, and cost-research claim on this page is linked to a primary source: California’s Department of Health Care Services and Department of Public Health, the CDC, SAMHSA, NIDA, the California Legislature’s own bill text, and peer-reviewed health economics literature. The pricing ranges are labeled as market observation, not government statistics, because that is what they are. Where a figure comes from a study published years ago, the year is stated so you can judge how much inflation to apply.
This article has not been reviewed by a physician, and it makes no clinical recommendation. It cannot tell you what level of care you or a family member needs. That determination requires an assessment by a licensed clinician using validated criteria, and no amount of published pricing data substitutes for it. What this page can do is stop you from being surprised by a bill, and stop you from concluding that treatment is out of reach when a fully funded route may be sitting in front of you.
RehabTreatmentCost.com publishes cost transparency research across levels of care and geographies. Our treatment options overview and editorial background explain the wider project.
Editorial and research support for this guide was provided by Optimo Results, a digital strategy firm working across healthcare, behavioral health, and wellness. Their subject-matter teams work extensively with addiction treatment providers and medical detox centers in the United States and United Kingdom, which informed the operational detail on how facilities structure and bill their programs.
Where to verify anything on this page yourself
California’s Department of Health Care Services operates a statewide, non-emergency substance use disorder referral line that routes callers to their county’s services. SAMHSA’s FindTreatment.gov lets you filter licensed facilities by payment type, including sliding-scale and payment-assistance options. Both are free, neither sells your information, and both are linked in the references below.
References and Citations
- California Department of Health Care Services. Drug Medi-Cal Organized Delivery System. Sacramento, CA: DHCS. Available at: https://www.dhcs.ca.gov/provgovpart/Pages/Drug-Medi-Cal-Organized-Delivery-System.aspx
- California Department of Health Care Services. Drug Medi-Cal Overview. Sacramento, CA: DHCS. Available at: https://www.dhcs.ca.gov/services/drug-medi-cal-overview/
- California Department of Health Care Services. Substance Use Disorder Treatment Services. Sacramento, CA: DHCS. Available at: https://www.dhcs.ca.gov/providers-partners/substance-use-disorder-treatment-services/
- California Department of Health Care Services. Substance Use Disorder Drug Medi-Cal and Drug Medi-Cal Organized Delivery System Penetration Rate Dashboard, FY 2022–23. Sacramento, CA: DHCS. Available at: https://www.dhcs.ca.gov/provgovpart/Documents/Substance Use Disorder-PPFD/Data Collection and Reporting/SUD-DMC-ODS-FY22-23-PenetrationRate.pdf
- California Department of Public Health, Substance and Addiction Prevention Branch. California Overdose Surveillance Dashboard. Sacramento, CA: CDPH. Available at: https://skylab.cdph.ca.gov/ODdash/
- California Department of Public Health. Overdose Prevention Initiative: Data and Reports. Sacramento, CA: CDPH. Available at: https://www.cdph.ca.gov/Programs/CCDPHP/sapb/Pages/Data.aspx
- California State Legislature. Senate Bill No. 855 (2019–2020): Health Coverage — Mental Health or Substance Use Disorders. Chapter 151, Statutes of 2020. Available at: https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200SB855
- Centers for Disease Control and Prevention. Drug Overdose Facts, Statistics and Data Resources. Atlanta, GA: CDC National Center for Injury Prevention and Control. Available at: https://www.cdc.gov/overdose-prevention/data-research/facts-stats/index.html
- Substance Abuse and Mental Health Services Administration. National Substance Use and Mental Health Services Survey (N-SUMHSS) 2024: Data on Substance Use and Mental Health Treatment Facilities. Publication No. PEP25-07-013. Rockville, MD: Center for Behavioral Health Statistics and Quality. Available at: https://www.samhsa.gov/data/report/2024-n-sumhss-annual-report
- Substance Abuse and Mental Health Services Administration. 2025 National Directory of Drug and Alcohol Use Treatment Facilities. Rockville, MD: SAMHSA. Available at: https://www.samhsa.gov/data/report/2025-national-directory-drug-and-alcohol-use-treatment
- National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). Bethesda, MD: National Institutes of Health. Available at: https://nida.nih.gov/sites/default/files/podat-3rdEd-508.pdf
- National Institute on Drug Abuse. Treatment and Recovery: Research Topics. Bethesda, MD: National Institutes of Health. Available at: https://nida.nih.gov/research-topics/treatment
- French, M.T., Popovici, I., and Tapsell, L. (2008). The economic costs of substance abuse treatment: Updated estimates and cost bands for program assessment and reimbursement. Journal of Substance Abuse Treatment, 35(4), 462–469.
- McCollister, K.E., Leff, J.A., Yang, X., et al. (2018). Cost of pharmacotherapy for opioid use disorders following inpatient detoxification. The American Journal of Managed Care, 24(11), 526–531.
- U.S. Department of Labor, Employee Benefits Security Administration. Mental Health and Substance Use Disorder Parity. Washington, DC: DOL. Available at: https://www.dol.gov/agencies/ebsa/laws-and-regulations/laws/mental-health-parity
- California Department of Managed Health Care. Help Center and Independent Medical Review. Sacramento, CA: DMHC. Available at: https://www.dmhc.ca.gov/
- Substance Abuse and Mental Health Services Administration. FindTreatment.gov: Confidential and Anonymous Resource for Persons Seeking Treatment. Rockville, MD: SAMHSA. Available at: https://findtreatment.gov/
Last researched and updated July 2026. Cost ranges reflect market conditions at the time of writing and change frequently. Regulatory summaries are provided for general information and are not legal advice.
